294 related articles for article (PubMed ID: 26818520)
1. Platelet-Activating Factor Receptors Mediate Excitatory Postsynaptic Hippocampal Injury in Experimental Autoimmune Encephalomyelitis.
Bellizzi MJ; Geathers JS; Allan KC; Gelbard HA
J Neurosci; 2016 Jan; 36(4):1336-46. PubMed ID: 26818520
[TBL] [Abstract][Full Text] [Related]
2. The Mixed-Lineage Kinase Inhibitor URMC-099 Protects Hippocampal Synapses in Experimental Autoimmune Encephalomyelitis.
Bellizzi MJ; Hammond JW; Li H; Gantz Marker MA; Marker DF; Freeman RS; Gelbard HA
eNeuro; 2018; 5(6):. PubMed ID: 30627663
[TBL] [Abstract][Full Text] [Related]
3. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
Gentile A; Musella A; Bullitta S; Fresegna D; De Vito F; Fantozzi R; Piras E; Gargano F; Borsellino G; Battistini L; Schubart A; Mandolesi G; Centonze D
J Neuroinflammation; 2016 Aug; 13(1):207. PubMed ID: 27566665
[TBL] [Abstract][Full Text] [Related]
4. Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease.
Ziehn MO; Avedisian AA; Dervin SM; O'Dell TJ; Voskuhl RR
Lab Invest; 2012 Aug; 92(8):1234-45. PubMed ID: 22525427
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease.
Ziehn MO; Avedisian AA; Dervin SM; Umeda EA; O'Dell TJ; Voskuhl RR
J Neurosci; 2012 Sep; 32(36):12312-24. PubMed ID: 22956822
[TBL] [Abstract][Full Text] [Related]
6. Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis.
Potter LE; Paylor JW; Suh JS; Tenorio G; Caliaperumal J; Colbourne F; Baker G; Winship I; Kerr BJ
J Neuroinflammation; 2016 Jun; 13(1):142. PubMed ID: 27282914
[TBL] [Abstract][Full Text] [Related]
7. Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis.
Howell OW; Rundle JL; Garg A; Komada M; Brophy PJ; Reynolds R
J Neuropathol Exp Neurol; 2010 Oct; 69(10):1017-1033. PubMed ID: 20838243
[TBL] [Abstract][Full Text] [Related]
8. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI
Front Immunol; 2018; 9():2588. PubMed ID: 30464764
[TBL] [Abstract][Full Text] [Related]
9. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
Duan RN; Yang CL; Du T; Liu A; Wang AR; Sun WJ; Li X; Li JX; Yan CZ; Liu QJ
J Neuroinflammation; 2021 Jun; 18(1):145. PubMed ID: 34183017
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
Ziehn MO; Avedisian AA; Tiwari-Woodruff S; Voskuhl RR
Lab Invest; 2010 May; 90(5):774-86. PubMed ID: 20157291
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of colony-stimulating factor-1 in mouse spinal cord with experimental autoimmune encephalomyelitis correlates with microglial activation and neuronal loss.
Gushchina S; Pryce G; Yip PK; Wu D; Pallier P; Giovannoni G; Baker D; Bo X
Glia; 2018 Oct; 66(10):2108-2125. PubMed ID: 30144320
[TBL] [Abstract][Full Text] [Related]
12. Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination.
Une H; Yamasaki R; Nagata S; Yamaguchi H; Nakamuta Y; Indiasari UC; Cui Y; Shinoda K; Masaki K; Götz M; Kira JI
J Neuroinflammation; 2021 Jun; 18(1):126. PubMed ID: 34090477
[TBL] [Abstract][Full Text] [Related]
13. Reduced Microglial Activity and Enhanced Glutamate Transmission in the Basolateral Amygdala in Early CNS Autoimmunity.
Acharjee S; Verbeek M; Gomez CD; Bisht K; Lee B; Benoit L; Sharkey KA; Benediktsson A; Tremblay ME; Pittman QJ
J Neurosci; 2018 Oct; 38(42):9019-9033. PubMed ID: 30185466
[TBL] [Abstract][Full Text] [Related]
14. Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor.
Kihara Y; Ishii S; Kita Y; Toda A; Shimada A; Shimizu T
J Exp Med; 2005 Sep; 202(6):853-63. PubMed ID: 16172262
[TBL] [Abstract][Full Text] [Related]
15. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.
Parodi B; Rossi S; Morando S; Cordano C; Bragoni A; Motta C; Usai C; Wipke BT; Scannevin RH; Mancardi GL; Centonze D; Kerlero de Rosbo N; Uccelli A
Acta Neuropathol; 2015 Aug; 130(2):279-95. PubMed ID: 25920452
[TBL] [Abstract][Full Text] [Related]
16. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
[TBL] [Abstract][Full Text] [Related]
17. Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one--time administration of encephalitogenic T cells.
Kurkowska-Jastrzębska I; Swiątkiewicz M; Zaremba M; Cudna A; Piechal A; Pyrzanowska J; Widy-Tyszkiewicz E; Członkowska A
Neuroscience; 2013 Sep; 248():690-8. PubMed ID: 23806721
[TBL] [Abstract][Full Text] [Related]
18. Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.
Wilmes AT; Reinehr S; Kühn S; Pedreiturria X; Petrikowski L; Faissner S; Ayzenberg I; Stute G; Gold R; Dick HB; Kleiter I; Joachim SC
J Neuroinflammation; 2018 Jun; 15(1):183. PubMed ID: 29903027
[TBL] [Abstract][Full Text] [Related]
19. Microglial Pruning: Relevance for Synaptic Dysfunction in Multiple Sclerosis and Related Experimental Models.
Geloso MC; D'Ambrosi N
Cells; 2021 Mar; 10(3):. PubMed ID: 33804596
[TBL] [Abstract][Full Text] [Related]
20. Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis.
Rossi S; Lo Giudice T; De Chiara V; Musella A; Studer V; Motta C; Bernardi G; Martino G; Furlan R; Martorana A; Centonze D
Br J Pharmacol; 2012 Feb; 165(4):861-9. PubMed ID: 21740406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
